These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 27102512)
21. Diabetic dyslipidemia and the heart. Vasudevan AR; Garber AJ Heart Fail Clin; 2006 Jan; 2(1):37-52. PubMed ID: 17386875 [No Abstract] [Full Text] [Related]
22. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550 [TBL] [Abstract][Full Text] [Related]
23. The future of diagnosing NASH - could a simple blood test be the key? Francque S; Vonghia L Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):995-997. PubMed ID: 28862886 [No Abstract] [Full Text] [Related]
24. Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease. Byrne CD; Targher G Gastroenterology; 2016 Jan; 150(1):7-10. PubMed ID: 26602219 [No Abstract] [Full Text] [Related]
25. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183 [No Abstract] [Full Text] [Related]
26. Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease. Elsheikh E; Younoszai Z; Otgonsuren M; Hunt S; Raybuck B; Younossi ZM J Gastroenterol Hepatol; 2014; 29(7):1528-34. PubMed ID: 25587619 [No Abstract] [Full Text] [Related]
27. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease. Sanyal AJ; Mathurin P; Nagy LA Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520 [No Abstract] [Full Text] [Related]
28. The association between primary bacteremia of presumed gastrointestinal origin and nonalcoholic fatty liver disease. Nseir W; Artul S; Nasrallah N; Mahamid M Dig Liver Dis; 2016 Mar; 48(3):343-4. PubMed ID: 26534773 [No Abstract] [Full Text] [Related]
38. Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population. Xu X; Alanaeme J; Wen Y; Colantonio LD; Muntner P; Long MT Gastroenterology; 2023 Apr; 164(4):688-689.e4. PubMed ID: 36623777 [No Abstract] [Full Text] [Related]
39. The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemic. Mrad RA; Merjaneh N; Mubarak G; Lopez R; Zein NN; Alkhouri N Hepatology; 2016 Oct; 64(4):1386-7. PubMed ID: 26991537 [No Abstract] [Full Text] [Related]
40. [Nonalcoholic fatty liver disease: What do we know and what will we have to learn?]. Volkova NI; Porksheyan MI Ter Arkh; 2017; 89(2):91-98. PubMed ID: 28393828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]